WMAHSN is looking for a Medicines Optimisation Lead for its Medicines Optimisation and Management programme, due to AHSN funding this will be offered as a 12 month fixed term contract.
West Midlands Academic Health Science Network (WMAHSN) is one of 15 regional AHSNs licensed by NHS England with the purpose of spreading the adoption of innovation at scale and pace to improve health and wellbeing, and to deliver economic benefits. WMAHSN is hosted by UHB NHS Foundation NHS Trust.
By catalysing partnerships between the health and care sector, academia, business and patients, citizens and the third sector, WMAHSN identifies innovations that address the health needs of the region’s population, drive down costs and attract investment and jobs into the West Midlands. Programmes of work are established to take the most attractive innovations forward to accelerate their uptake regionally, nationally and internationally.
One of the AHSN’s strategic priorities is medicines optimisation and management with an emphasis on sustaining the achievements to date in the delivery of PINCER, Transfer of Care around Medicines, electronic repeat dispensing and medicines administration in care homes. The priority encompasses programmes, projects, events and meetings involving a large and diverse range of organisations and individuals. The ambition is to support organisations and individuals with the infrastructure and capability to improve unnecessary prescribing, reduce prescribing errors and support the interface between secondary and primary care - improving quality, patient safety and experience whilst reducing costs.
The post holder will be a pharmacist with strong project management and business planning skills, be a strong self-motivated and flexible team player and be able to lead on a number of individual projects working with the other AHSN Medicines Optimisation Leads, other Regional programme Leads, and Directors. The post holder will also need to be a good communicator.
We are looking for a pharmacist with a background in medicines optimisation who can help develop this necessary and exciting programme of work. For further information please contact Amy Owen.